EXACT SCIENCES CORP is 4.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($20.03 B vs $4.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EXAS | CAI |
|---|---|---|
| Market cap | $20.03 B | $4.85 B |
| US-listed rank | #619 | #1404 |
| Revenue (latest FY) | $3.25B | $812.03M |
| Net income (latest FY) | -$207.95M | -$68.09M |
| Net margin | -6.4% | -8.4% |
| SEC filings | 1,834 | 102 |
EXACT SCIENCES CORP is 4.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($20.03 B vs $4.85 B).
In their latest fiscal years, EXACT SCIENCES CORP reported $3.25B in revenue while Caris Life Sciences, Inc. reported $812.03M.
Full pages: EXACT SCIENCES CORP and Caris Life Sciences, Inc., or browse the full rankings.